SpyGlass Pharma SGP
NASDAQ SGP
$26.50 +0.50 (+1.92%)
At close: Oct 1, 2026 · 4:00 PM EDT

SpyGlass Pharma (SGP) Liabilities and Shareholders Equity (2024 - 2026)

Updated

SpyGlass Pharma's Liabilities and Shareholders Equity was $243.43 million in Q2 2026.

Analysis

SpyGlass Pharma (SGP) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at SpyGlass Pharma came in at $115.87 million, up 396.9% from FY2024.

  • In earlier years, Liabilities and Shareholders Equity was $23.32 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 SpyGlass Pharma 869.60 Mn 869.60 Mn - 243.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 243.43 Mn
Dec 31, 2025 115.87 Mn
Dec 31, 2024 23.32 Mn
API Access

SpyGlass Pharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SGP&period=max&api_key=YOUR_API_KEY